Abstract
Gastrointestinal disorders occur in up to 40% of the population in the UK. Treatment of these disorders accounts for a large proportion of the NHS prescribing budget. Although the aetiology of gastrointestinal disorders is complex, the contribution of Helicobacter pylori in the development of gastric and duodenal ulceration, dyspepsia and various forms of cancer, continues to be discovered. The increasing interest in the bacterium and the need for its eradication continues. Exploration of how non-invasive biochemical tests can detect the bacterium and combination therapy can eradicate it has improved the management of H. pylori-associated conditions. The need for screening protocols which target ‘at-risk’ groups and routinely investigate people who suffer from dyspepsia, should be encouraged as this can maybe reduce the incidence of H. pylori-induced gastric infections. The nurse prescriber can have an educational and management role to play in the eradication of this bacterium.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
